New CDC Laboratory Test for Zika Virus Authorized for Emergency Use by FDA - Media Statement

In response to a request from the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration (FDA) yesterday issued an Emergency Use Authorization (EUA) for the Trioplex Real-time RT-PCR Assay, a diagnostic tool for Zika virus that will be distributed to qualified laboratories.

This Coalition transmission preserves metadata, trust context, and source routing for a Public Intelligence item from CDC. The complete article remains with the original publisher.

Content handling is marked as Public Domain. Use the source article link for the full report, updates, corrections, and publisher-controlled context.